Purine-mediated growth inhibition caused by a pyrE mutation in Escherichia coli K-12.
A purine-sensitive phenotype results from a previously described mutation in the structural gene (pyrE) for orotate phosphoribosyltransferase (OPT) in Escherichia coli K-12. OPT from both the mutant and the wild-type was partially inhibited by adenine and adenosine, although other purine derivatives were not effective for this inhibition. The Km values of the mutant OPT were 580 and 760 microM for orotate and 5'-phosphoribosyl-1'-pyrophosphate (PRib-PP), respectively, whereas the corresponding values for the wild-type OPT were 40 and 60 microM. The intracellular level of PRib-PP was decreased to less than 15% of the normal level when purine derivatives were added to exponentially growing cultures of both the parent and mutant strains. However, this decrease of the PRib-PP level was not found in strains derived from the mutant, in which the purine-sensitive phenotype was suppressed by a secondary mutation. The purine-sensitive phenotype was caused by retardation of the pyrimidine de novo pathway, when the intracellular level of PRib-PP was diminished by exogenously supplied purine derivatives.
D000225:Adenine / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics / Q000254:growth & development*; D005796:Genes; D005798:Genes, Bacterial; D007700:Kinetics; D009154:Mutation; D009962:Orotate Phosphoribosyltransferase / Q000235:genetics* / Q000378:metabolism; D010430:Pentosyltransferases / Q000235:genetics*; D011687:Purines / Q000494:pharmacology*
D011687:Purines; D010430:Pentosyltransferases; D009962:Orotate Phosphoribosyltransferase; D000225:Adenine; D000241:Adenosine